drugset
Drugs / Japanese Encephalitis Vaccine (Vero Cell), Inactivated
last change Nov 2023 re-read 9 days ago

Japanese Encephalitis Vaccine (Vero Cell), Inactivated

Vaccine

Developed for
Japanese encephalitis
Investigated by
Liaoning Chengda Biotechnology CO., LTD · Zhejiang Provincial Center for Disease Control and Prevention

Trials 2

today NCT06825312 · Ph 4 NCT04817917 · Ph 4
20212022202320242025202620272028202920302031
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06825312 Nov 2023 → Dec 2030 expected Japanese encephalitis Liaoning Chengda Biotechnology CO., LTD Active not recruiting No outcome recorded
Phase 4 NCT04817917 Mar 2021 → Sep 2022 Japanese encephalitis Zhejiang Provincial Center for Disease Control and Prevention Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Japanese Encephalitis Vaccine (Vero Cell), Inactivated ClinicalTrials.gov intervention name — accepted as the source's own label NCT06825312 ↗
1

NCT04817917 ↗
Modality Vaccine “by JE attenuated live vaccine (JEV-L) or/and inactivated vaccine (JEV-I)” NCT04817917 ↗
Route Intramuscular “administered in the deltoid area of lateral arm by intramuscular injection” NCT06825312 ↗